4)- Yiqun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe Xu. Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer.Signal transduction and targeted therapy. 2023, 8 (1): 429
5)- Chi Wang Ip, Jörg Wischhusen. Versatile guardians: regenerative regulatory T cells in Parkinson's disease rodent models.Signal transduction and targeted therapy. 2023, 8 (1): 430
8)- Dieter Kabelitz. The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease.Signal transduction and targeted therapy. 2023, 8 (1): 433
15)- Lisa Müller, Tony Gutschner, Mechthild Hatzfeld. Going only half the way: cell cycle exit after the G1 restriction point.Signal transduction and targeted therapy. 2023, 8 (1): 440
19)- Anikó Keller-Pintér, Tamás Korcsmáros, Tibor Vellai. Managing type 2 diabetes: targeting a microbial enzyme as a novel treatment option.Signal transduction and targeted therapy. 2023, 8 (1): 444
21)- Christopher C Udoye, Rudolf A Manz. IgE-Mast cell mediated allergy: a sensor of food quality.Signal transduction and targeted therapy. 2023, 8 (1): 446
22)- Wenlu Li, Steffen Tiedt, Eng H Lo. Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer's disease.Signal transduction and targeted therapy. 2023, 8 (1): 447
29)- Lei Yu, Pengcheng Zhao, Yaoliang Sun, Zening Zheng, Wenhao Du, Lishan Zhang, Yaxu Li, Longyan Xie, Shilin Xu, Ping Wang. Development of a potent benzonitrile-based inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with antitumor efficacy.Signal transduction and targeted therapy. 2023, 8 (1): 454
30)- Md Entaz Bahar, Hyun Joon Kim, Deok Ryong Kim. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.Signal transduction and targeted therapy. 2023, 8 (1): 455
35)- Marianne Boes, Pascal Falter-Braun. Long-COVID-19: the persisting imprint of SARS-CoV-2 infections on the innate immune system.Signal transduction and targeted therapy. 2023, 8 (1): 460
36)- Harald F Langer. An unexpected cellular fountain of youth: platelets provide factors rejuvenating brain functions.Signal transduction and targeted therapy. 2023, 8 (1): 461
41)- Danyi Ao, Xuemei He, Jian Liu, Li Xu. Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period.Signal transduction and targeted therapy. 2023, 8 (1): 466